Capabilities
Experienced & Relationship Focused
Regardless of whether challenges are immediate or years away, Medicus has the health economic and access strategy expertise to help identify, demonstrate, and communicate value throughout the product journey.
Evidence Generation
Transform data into knowledge
Evidence forms the foundation of every value story. Careful data analytics can reveal opportunities for improving patient outcomes and maximizing value. We apply advanced methodologies to a broad array of data sources—tailoring the approach and resources for each engagement—to deliver insights that guide the value story.
Value Demonstration
Using today's data to guide tomorrow's decisions
Developing a cohesive value story from different data sources can be challenging. We partner with our clients to create and optimize models which answer complex questions and drive strategic decisions. We have extensive experience building models in health care that help our clients with critical business decisions and regulatory submissions.
Access Strategy & Policy
Market research and commercial support to steer strategic decisions
As the global healthcare industry becomes more complex, successfully navigating access and policy channels is becoming critical for delivering innovative therapies to patients. At Medicus, we leverage deep industry experience, innovative market research, and hands-on commercial support to guide policy and access decisions for our clients.
Select experience
We help build the value story and communicate with decision makers throughout the product journey.
We combine analytical expertise with industry knowledge to provide tailored solutions for our clients.
See ExamplesFocused Examples
01.
Patient support programs aim to help patients adhere to prescribed treatment; however, their benefits for patients and providers have not been quantified. We conducted studies to demonstrate short- and long-term benefits of patient support programs to patients and payers.
View Study02.
Gene therapies present lifelong cures for patients but novel reimbursement challenges for payers. We balanced methodological rigor with a creative approach to support the first-ever approved gene therapy.
View Study03.
Determining the appropriate price for new treatments can be challenging, especially for innovative therapies which elevate the standard of care for patients. Using a multi-pronged market research approach, we enabled our client to optimize their pricing strategy while generating robust evidence to clearly communicate the value proposition to economic-decision makers.
View Study04.
Reimbursement restrictions can provide short-term savings for payers but have unintended and negative consequences for patients. Using real-world data, we showed the harmful effects of copay accumulator adjustment programs on specialty drug adherence.
View StudyRegardless of whether challenges are immediate or years away, Medicus can help identify, demonstrate, and communicate a product’s value story.
We're eager to discuss new challenges and how we can help improve value stories.
Contact UsWe are continuously looking for teammates to strengthen and diversify our capabilities.
See openings